• Contact Us

Feb. 20: Last day to receive early registration rates for #ASGCT2025! Lock in your spot to join us in New Orleans!

• Annual Meeting
  • Register
  • Sponsor & Exhibit
  • Future Annual Meetings
  • Annual Meeting Archives
    • 27th Annual Meeting Video Archive

  • Program
    • Workshops
    • Keynote Speakers

  • Abstracts
    • Present
    • Awards
    • Topics
• Membership
  • Video Library
    • Annual Meeting
    • Cancer
    • Career Skills
    • Gene Editing
    • Patients and Clinicians
    • Regulatory
    • Viral Vectors

  • Become a Member
  • Get Involved
  • Career Center
  • ASGCT Abstracts
    • Abstract Submission Windows
  • Volunteer

  • My Profile
  • Economy-Based Rates
  • Awards
  • Membership Directory
  • Scientific Committees
  • Standing Committees
• Events
  • Around the World: Advanced Therapy Medicinal Production in South America
  • Professional Development Cafés
    • Intellectual Property and What You Need to Know

  • Class Considerations on Immunogenicity for AAV GT Products: Assessing Current Practice + New Data
  • Empowering Patients 2025: A Cell and Gene Therapies Summit
  • The Big Picture: Accountability in an Evolving Ecosystem

  • Molecular Therapy Presents: Extracellular Vesicles
  • Non-ASGCT Events
• Awards
  • Honorific Awards
    • Outstanding Achievement Award
    • Outstanding New Investigator Awards
    • George Stamatoyannopoulos Mentorship Award
    • Award for Excellence in Advancing Diversity, Equity, and Inclusion
    • Exemplary Service Award

  • Annual Meeting Awards
  • Underrepresented Populations in Gene and Cell Therapy
  • Mavis Agbandje-McKenna Scholarship and Fund

  • Career Development Awards
  • Congressional Policy Fellowship
• Outreach
  • Clinical Trials Finder
  • Community Quick Takes
    • Informed Consent
    • State of the Field Highlights + Approvals for CGT in 2023
    • Access to Approved Cell and Gene Therapies
    • Genetic Testing and Clinical Trial Eligibility
  • Diversity, Equity, and Inclusion
    • Biotech Discovery Labs Program

  • Patient Education: Gene Therapy 101
    • Gene Therapy Basics
    • Gene Therapy Approaches
    • Clinical Trials Process
    • Vectors 101
    • Gene Editing
  • Global Outreach

  • Patient Education: Condition Treatments
    • Beta Thalassemia & Other Blood Disorders
    • CALD and MLD
    • Spinal Muscular Atrophy
    • CAR-T Basics
    • Hemophilia
• Publications
  • ASGCT Blog
  • The Patient Press
    • December 2024
  • The Vector
  • Quarterly Gene, Cell, and RNA Therapy Landscape Report

  • ASGCT Podcast Network
    • Giants of Gene Therapy
    • The Issue
    • The Molecular Therapy Podcast
  • The Advocate
    • Subscribe to The Advocate

  • Molecular Therapy Family
    • Molecular Therapy Presents Extracellular Vesicles
    • Cell Press Webinar: Advances in Viral Vector Gene Delivery for CT Biomanufacturing
    • Molecular Therapy
    • MT Methods & Clinical Development
    • MT Nucleic Acids
    • MT Oncology
• Advocacy
  • Events and Opportunities
    • Policy Summit
    • ASGCT-FDA Liaison Meeting
    • Cell + Gene Therapy Science Series
    • Congressional Policy Fellowship
    • FDA & ASGCT: Immune Responses to AAV Vectors

  • Policy Priorities
    • Patient Access Overview
    • Regulatory Policy
    • Research Funding

  • The Advocate
    • Subscribe to The Advocate
  • Policy Statements & Letters
• About
  • Leadership
    • Board of Directors
    • Scientific Committees
    • Standing Committees
    • Staff
  • Work at ASGCT
    • Abstracts Manager
    • Administrative Coordinator
    • Senior Marketing Manager

  • Media
  • Our Culture
  • Strategic Plan
  • Meeting Code of Conduct
  • Terms and Conditions

  • Mission & Vision
    • Bylaws
  • Support ASGCT
    • Annual Meeting Support
    • Advertise in ASGCT Publications
    • Digital Programs
    • Giving
    • Year-Round Support

The Advocate

ASGCT's policy and advocacy-focused newsletter.

Subscribe to The Advocate

Receive The Advocate in your inbox every month to stay up to date on ASGCT's policy and advocacy-related actions to advance gene and cell therapies! 

Subscribe

Read Archived Issues

September 2024

In this issue: Read our recent comments to FDA and CMS, check out our latest Community Quick Takes module on genetic testing and clinical trial access, stay up to date on policy news, and more.

Read the issue